These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Evaluation of recombinant dengue viral envelope B domain protein antigens for the detection of dengue complex-specific antibodies. Simmons M; Porter KR; Escamilla J; Graham R; Watts DM; Eckels KH; Hayes CG Am J Trop Med Hyg; 1998 Feb; 58(2):144-51. PubMed ID: 9502595 [TBL] [Abstract][Full Text] [Related]
24. Improved sensitivity in the antibody-forming cell assay for Japanese encephalitis virus in mice by optimal fixation of cells and avidin-biotin complex (ABC) immunocytochemistry. García-García J; Takashima I; Kariwa H; Hashimoto N J Immunol Methods; 1993 Jan; 157(1-2):259-67. PubMed ID: 8423371 [TBL] [Abstract][Full Text] [Related]
25. Direct random insertion of an influenza virus immunologic determinant into the NS1 glycoprotein of a vaccine flavivirus. Rumyantsev AA; Zhang ZX; Gao QS; Moretti N; Brown N; Kleanthous H; Delagrave S; Guirakhoo F; Collett MS; Pugachev KV Virology; 2010 Jan; 396(2):329-38. PubMed ID: 19913267 [TBL] [Abstract][Full Text] [Related]
26. Enzyme-linked immunosorbent assays using novel Japanese encephalitis virus antigen improve the accuracy of clinical diagnosis of flavivirus infections. Chiou SS; Crill WD; Chen LK; Chang GJ Clin Vaccine Immunol; 2008 May; 15(5):825-35. PubMed ID: 18337381 [TBL] [Abstract][Full Text] [Related]
27. High-throughput neutralization assay for multiple flaviviruses based on single-round infectious particles using dengue virus type 1 reporter replicon. Matsuda M; Yamanaka A; Yato K; Yoshii K; Watashi K; Aizaki H; Konishi E; Takasaki T; Kato T; Muramatsu M; Wakita T; Suzuki R Sci Rep; 2018 Nov; 8(1):16624. PubMed ID: 30413742 [TBL] [Abstract][Full Text] [Related]
28. Altered effector functions of virus-specific and virus cross-reactive CD8+ T cells in mice immunized with related flaviviruses. Trobaugh DW; Yang L; Ennis FA; Green S Eur J Immunol; 2010 May; 40(5):1315-27. PubMed ID: 20213733 [TBL] [Abstract][Full Text] [Related]
30. ELISA for detecting dengue and Japanese encephalitis viral antigen in mosquitoes. Sithiprasasna R; Strickman D; Innis BL; Linthicum KJ Ann Trop Med Parasitol; 1994 Aug; 88(4):397-404. PubMed ID: 7979627 [TBL] [Abstract][Full Text] [Related]
31. Saron WAA; Rathore APS; Ting L; Ooi EE; Low J; Abraham SN; St John AL Sci Adv; 2018 Jul; 4(7):eaar4297. PubMed ID: 29978039 [TBL] [Abstract][Full Text] [Related]
32. Failure of Japanese encephalitis vaccine and infection in inducing neutralizing antibodies against West Nile virus, People's Republic of China. Tang F; Zhang JS; Liu W; Zhao QM; Zhang F; Wu XM; Yang H; Ly H; Cao WC Am J Trop Med Hyg; 2008 Jun; 78(6):999-1001. PubMed ID: 18541783 [TBL] [Abstract][Full Text] [Related]
33. Detection of specific immunoglobulin M antibody to different flaviviruses by use of enzyme-labeled antigens. Schmitz H; Emmerich P J Clin Microbiol; 1984 May; 19(5):664-7. PubMed ID: 6330165 [TBL] [Abstract][Full Text] [Related]
34. Solid-phase radioimmunoassay for antibodies to flavivirus structural and nonstructural proteins. Trent DW; Harvey CL; Qureshi A; LeStourgeon D Infect Immun; 1976 May; 13(5):1325-33. PubMed ID: 1270142 [TBL] [Abstract][Full Text] [Related]
35. Poxvirus-based Japanese encephalitis vaccine candidates induce JE virus-specific CD8+ cytotoxic T lymphocytes in mice. Konishi E; Kurane I; Mason PW; Shope RE; Ennis FA Virology; 1997 Jan; 227(2):353-60. PubMed ID: 9018134 [TBL] [Abstract][Full Text] [Related]
36. Differences in fusogenicity and mouse neurovirulence of Japanese encephalitis viruses. Higgs S; Gould EA Arch Virol; 1991; 119(1-2):119-33. PubMed ID: 1650549 [TBL] [Abstract][Full Text] [Related]
37. Analysis of computer-predicted antibody inducing epitope on Japanese encephalitis virus. Kutubuddin M; Gore MM; Banerjee K; Ghosh SN; Kolaskar AS Acta Virol; 1993 Dec; 37(6):417-28. PubMed ID: 7516621 [TBL] [Abstract][Full Text] [Related]
38. Development and characterization of serotype-specific monoclonal antibodies against the dengue virus-4 (DENV-4) non-structural protein (NS1). Gelanew T; Hunsperger E Virol J; 2018 Feb; 15(1):30. PubMed ID: 29409531 [TBL] [Abstract][Full Text] [Related]
39. Long-term immunogenicity of an initial booster dose of an inactivated, Vero cell culture-derived Japanese encephalitis vaccine (JE-VC) and the safety and immunogenicity of a second JE-VC booster dose in children previously vaccinated with an inactivated, mouse brain-derived Japanese encephalitis vaccine. Yun KW; Lee HJ; Park JY; Cho HK; Kim YJ; Kim KH; Kim NH; Hong YJ; Kim DH; Kim HM; Cha SH Vaccine; 2018 Mar; 36(11):1398-1404. PubMed ID: 29429815 [TBL] [Abstract][Full Text] [Related]
40. Enhancing the utility of a prM/E-expressing chimeric vaccine for Japanese encephalitis by addition of the JEV NS1 gene. Ishikawa T; Wang G; Widman DG; Infante E; Winkelmann ER; Bourne N; Mason PW Vaccine; 2011 Oct; 29(43):7444-55. PubMed ID: 21798299 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]